Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anti-NLRP3 Inflammasome Natural Compounds: An Update
Baolong Liu, Jiujiu Yu
Biomedicines (2021) Vol. 9, Iss. 2, pp. 136-136
Open Access | Times Cited: 20

Showing 20 citing articles:

Pharmacological Inhibition of the NLRP3 Inflammasome: Structure, Molecular Activation, and Inhibitor-NLRP3 Interaction
Qiang Ma
Pharmacological Reviews (2023) Vol. 75, Iss. 3, pp. 487-520
Open Access | Times Cited: 75
Advancing combination treatment with glycyrrhizin and boswellic acids for hospitalized patients with moderate COVID-19 infection: a randomized clinical trial
Adel A. Gomaa, Hamdy Saad Mohamed, Rasha B. Abd-ellatief, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 2, pp. 477-486
Open Access | Times Cited: 29
Molecular Foundations of Inflammatory Diseases: Insights into Inflammation and Inflammasomes
Mi Eun Kim, Jun Sik Lee
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 1, pp. 469-484
Open Access | Times Cited: 5
NLRP3 inflammasome in health and disease (Review)
Haoran Wang, Li Ma, Weiran Su, et al.
International Journal of Molecular Medicine (2025) Vol. 55, Iss. 3
Closed Access
NLRP3 inflammasomes pathway: a key target for Metformin
Yasamin Hosseini, Amirhossein Niknejad, Ayeh Sabbagh Kashani, et al.
Inflammopharmacology (2025)
Closed Access
NLRP3 Inflammasome in Atherosclerosis: Putting Out the Fire of Inflammation
Bo‐Zong Shao, Haiyan Xu, Yicheng Zhao, et al.
Inflammation (2022) Vol. 46, Iss. 1, pp. 35-46
Closed Access | Times Cited: 18
Narirutin exerts anti‐inflammatory activity by inhibiting NLRP3 inflammasome activation in macrophages
MyongHak Ri, Ming Yue Li, Yue Xing, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 4, pp. 1293-1308
Closed Access | Times Cited: 10
Mesenchymal stem cells (MSCs) and MSC‐derived exosomes in animal models of central nervous system diseases: Targeting the NLRP3 inflammasome
Shahrzad Nazari, Seyed Mahmoud Pourmand, Elahe Motevaseli, et al.
IUBMB Life (2023) Vol. 75, Iss. 10, pp. 794-810
Closed Access | Times Cited: 10
The NLRP3 inflammasome: Mechanisms of activation, regulation, and role in diseases
Mina Dadkhah, Mohammadreza Sharifi
International Reviews of Immunology (2024), pp. 1-14
Closed Access | Times Cited: 3
Natural Compounds Oridonin and Shikonin Exhibit Potentially Beneficial Regulatory Effects on Select Functions of Microglia
Bridget K. Greuel, Dylan E. Da Silva, Victoria Robert-Gostlin, et al.
Brain Sciences (2024) Vol. 14, Iss. 4, pp. 328-328
Open Access | Times Cited: 2
Breaking the barriers: Overcoming cancer resistance by targeting the NLRP3 inflammasome
Nazanin Pazhouhesh Far, Mahsa Hajiheidari Varnousafaderani, Ferdos Faghihkhorasani, et al.
British Journal of Pharmacology (2024)
Open Access | Times Cited: 2
A Selective Review and Virtual Screening Analysis of Natural Product Inhibitors of the NLRP3 Inflammasome
Sherihan El‐Sayed, Sally Freeman, Richard A. Bryce
Molecules (2022) Vol. 27, Iss. 19, pp. 6213-6213
Open Access | Times Cited: 13
Novel Activity of ODZ10117, a STAT3 Inhibitor, for Regulation of NLRP3 Inflammasome Activation
Ju‐Hui Kang, Se-Bin Lee, Jiu Seok, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6079-6079
Open Access | Times Cited: 7
Inflammasomes in Atherosclerosis—From Pathophysiology to Treatment
Panagiotis Theofilis, Evangelos Oikonomou, Christos Chasikidis, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 9, pp. 1211-1211
Open Access | Times Cited: 7
Fucoidan’s Molecular Targets: A Comprehensive Review of Its Unique and Multiple Targets Accounting for Promising Bioactivities Supported by In Silico Studies
Ahmed Zayed, Dalal A. Al-Saedi, Emmanuel O. Mensah, et al.
Marine Drugs (2023) Vol. 22, Iss. 1, pp. 29-29
Open Access | Times Cited: 6
Castanopsis sieboldii Extract Alleviates Acute Liver Injury by Antagonizing Inflammasome-Mediated Pyroptosis
Jae Min Kim, Sam Seok Cho, Sohi Kang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 11982-11982
Open Access | Times Cited: 3
Molecular Crossfires between Inflammasome Signalling and Dietary Small Molecule Inhibitors in Neurodegenerative Diseases: Implications for Medical Nutrition Therapy
Adeoye Bayo Olufunso, Adeoye Ayodeji David, Akano Oyedayo Phillips, et al.
EAS Journal of Biotechnology and Genetics (2024) Vol. 6, Iss. 04, pp. 68-80
Open Access
Phytochemical Profile and Antidiabetic, Antioxidant, and Anti-Inflammatory Activities of Gypsophila paniculata Ethanol Extract in Rat Streptozotocin-Induced Diabetes Mellitus
Lia-Oxana Usatiuc, Marcel Pârvu, Raluca Maria Pop, et al.
Antioxidants (2024) Vol. 13, Iss. 9, pp. 1029-1029
Open Access
Anti-Inflammatory Properties of Biflavonoids Derived from Selaginella moellendorffii Hieron: Targeting NLRP3 Inflammasome-Dependent Pyroptosis
Xueyan Zhang, Jin Lu, You Wu, et al.
Journal of Ethnopharmacology (2024) Vol. 340, pp. 119172-119172
Closed Access
In-vitro inhibition of NLRP3 inflammasome by 3,6-dihydroxyflavone (3,6-DHF): a therapeutic strategy for the treatment of chronic inflammatory and autoimmune diseases
Farheen Mansoor, Almas Jabeen, Syeda Farah Shah, et al.
Molecular and Cellular Biochemistry (2022) Vol. 478, Iss. 3, pp. 555-570
Closed Access | Times Cited: 3
Exploring the Use of Medicinal Plants and Their Bioactive Derivatives as Alveolar NLRP3 Inflammasome Regulators during Mycobacterium tuberculosis Infection
Nontobeko E. Mvubu, Thamsanqa E. Chiliza
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9497-9497
Open Access | Times Cited: 3
Page 1

Scroll to top